CN Patent
CN102762576A — 苯并氧杂氮杂*pi3k抑制剂化合物和使用方法
Assigned to F Hoffmann La Roche AG · Expires 2012-10-31 · 14y expired
What this patent protects
本发明涉及式(I)苯并氧杂氮杂 化合物,包括其立体异构体、几何异构体、互变异构体或药用盐,其中Z 1 为CR 1 或N;Z 2 为CR 2 或N;Z 3 为CR 3 或N;Z 4 为CR 4 或N;且B为吡唑基环、咪唑基环或三唑基环,所述化合物具有抗癌活性且更具体为抑制PI3激酶活性。
USPTO Abstract
本发明涉及式(I)苯并氧杂氮杂 化合物,包括其立体异构体、几何异构体、互变异构体或药用盐,其中Z 1 为CR 1 或N;Z 2 为CR 2 或N;Z 3 为CR 3 或N;Z 4 为CR 4 或N;且B为吡唑基环、咪唑基环或三唑基环,所述化合物具有抗癌活性且更具体为抑制PI3激酶活性。
Drugs covered by this patent
- Itovebi (INAVOLISIB) · Genentech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.